triadans.blogg.se - Developer amphetamine macgustafsongithub

#Developer amphetamine macgustafsongithub how to#
#Developer amphetamine macgustafsongithub free#
#Developer amphetamine macgustafsongithub mac#

#Developer amphetamine macgustafsongithub mac#

Continue raise awareness of Apple's actions and essentially wait for Apple to reinstate Amphetamine on the Mac App Store.

Immediately begin work on rebranding Amphetamine and hopefully, get the newly-named app back on the Mac App Store.

Should Apple refuse to reverse their decision, and thus remove Amphetamine from the Mac App Store, I will likely do one of the following: Hopefully, Apple will hear the voices of the Mac community and reconsider their decision. I do not personally have much faith in Apple reversing course based on the appeal alone, however. I have filed an appeal/challenge to the Guidelines violation accusation directly with Apple.

Tell your friends/family/colleagues on your next Zoom call.

Apple has threatened to remove Amphetamine from the Mac App Store on January 12th, 2021 if Apple's demands are not met. Spread the word! Let the world know that you want to see Amphetamine.app continue to exist on the Mac App Store. Specifically, your app name and icon include references to controlled substances, pills.” How Can I Help? “Your app appears to promote inappropriate use of controlled substances. Facilitating the sale of marijuana, tobacco, or controlled substances (except for licensed pharmacies) isn’t allowed." Apps that encourage minors to consume any of these substances will be rejected. What Guideline Has Apple Accused Amphetamine of Violating?Īpple has accused Amphetamine of violating the following guideline:ġ.4.3 Apps that encourage consumption of tobacco and vape products, illegal drugs, or excessive amounts of alcohol are not permitted on the App Store. It is also my belief that there are a lot of people out there who feel the same way as me, and want to see Amphetamine.app continue to flourish without a complete re-branding. It is my belief that Amphetamine is not in violation of any of Apple's Guidelines. On December 29th, 2020, a representative from Apple contacted and informed me that, after 6 years on the Mac App Store, Amphetamine had spontaneously began violating one of Apple's App Store Guidelines.Īpple then proceeded to threaten to remove Amphetamine from the Mac App Store on January 12th, 2021 if changes to the app were not made.

It currently has over 1,400 reviews and a 4.8 out of 5.0 rating in the US Mac App Store. Amphetamine has been on the Mac App Store since 2014 and it’s been downloaded over 432,800 times.

#Developer amphetamine macgustafsongithub free#

Thank you to all for sharing this story and helping to keep Amphetamine in the App Store.Īmphetamine is a free app that helps keep your Mac awake. On that call, an Apple representative stated that Apple now recognizes that the word "amphetamine" and the pill icon are being used "metaphorically", and in a "medical sense." Published by Elsevier B.V.On January 2nd, 2021, I received a call from Apple to discuss the results of my appeal.

#Developer amphetamine macgustafsongithub how to#

High study drop-out and poor medication adherence limits the strength of evidence and raises important clinical questions about how to improve treatment engagement and outcomes.Īmphetamine Dependence Methamphetamine Pharmacotherapy Treatment.Ĭopyright © 2018. No medicine has as yet demonstrated sufficient, consistent evidence of effectiveness to support its use in routine treatment. Six other medicines indicate the potential for efficacy, but the number of studies is too small to draw conclusions. Four RCTs of dexamphetamine suggest its benefit on secondary outcomes such as treatment retention, but not for reducing amphetamine use. Four of these medicines demonstrated some limited evidence of benefit for reducing amphetamine use: methylphenidate (as reported in three studies), bupropion (in three studies), modafinil (two studies), and naltrexone (one study). Five medications were subject to multiple RCTs.

Of these, 35 studies related to 33 level II quality randomized controlled trials (RCTs). A meta-narrative review approach was used to synthesize results.Ī total of 49 studies investigating 20 potential pharmacotherapies were eligible for inclusion. Studies on medications for amphetamine/methamphetamine dependence treatment were selected and assessed by two independent researchers. Medline, PsycINFO, Embase and the Cochrane Database of Systematic Reviews were searched from 1997 to 2012 and again from 2013 to 2016. This study aimed to identify medicines that have potential in improving treatment outcomes for people who are dependent on amphetamines. Establishing effective pharmacotherapy provides broader treatment options for people who are dependent on amphetamine and may encourage engagement in evidence-based behavioral treatment. Demand for treatment for amphetamine use is increasing internationally.